Patents by Inventor Joel Van Tuttle

Joel Van Tuttle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating HIV infections with 2',3'-dideoxy-3'-fluoro-5-chlorouridine
    Patent number: 5574149
    Abstract: A method for treating HIV infections comprising administering a composition whose active ingredient is 2',3'-dideoxy-3'-fluoro-5'-chlorouridine.
    Type: Grant
    Filed: May 17, 1993
    Date of Patent: November 12, 1996
    Assignee: Glaxo Wellcome Inc.
    Inventors: Joel Van Tuttle, Susan M. Daluge, Charlene L. Burns, George W. Koszalka, Thomas A. Krenitsky
  • Method for the treatment of protoza infections with 2.sup.1 -deoxy-2.sup.1 -fluoropurine nucleosides
    Patent number: 5420115
    Abstract: A method for treating two specific protozoal infections, Trichomonas vaginalis and Giardia lamblia, comprising the administration to a mammal in need thereof one of the following purine nucleosides:2,6-diamino-9-(2-deoxy-2-fluoro-.beta.-D-ribofuranosyl)-9H-purine2-amino-9-(2-deoxy-2-fluoro-.beta.-D-ribofuranosyl)-9H-purine2-amino-9-(2-deoxy-2-fluoro-.beta.-D-ribofuranosyl)-6-methoxy-9H-purine.
    Type: Grant
    Filed: September 2, 1992
    Date of Patent: May 30, 1995
    Assignee: Burroughs Wellcome Co.
    Inventors: Sylvia M. Tisdale, Joel Van Tuttle, Martin J. Slater, Susan M. Daluge, Wayne H. Miller, Thomas A. Krenitsky, George W. Koszalka
  • Treatment of adenovical infections with 3'-fluoro-5-halo uracil compounds
    Patent number: 5376644
    Abstract: 2',3'-Dideoxy-3'-fluoro pyrimidine nucleosides particularly 2', 3'-dideoxy-3'-fluorothymidine have been found to have particularly potent activity against adenovirus infections especially those caused by adenoviruses of scrotype 8. Such compounds are preferably presented in pharmaceutical formulations adapted for ophthalmic administration.
    Type: Grant
    Filed: December 24, 1992
    Date of Patent: December 27, 1994
    Assignee: Burroughs Wellcome Co.
    Inventors: John W. T. Selway, Joel Van Tuttle, Thomas A. Krenitsky
  • Therapeutic nucleosides
    Patent number: 5175274
    Abstract: This invention relates to certain 2'-fluoro nucleosides and pharmaceutically acceptable derivatives thereof and their use in the treatment of HIV infections. Also provided are pharmaceutical formulations and processes for the production of the compounds according to the invention.
    Type: Grant
    Filed: October 4, 1991
    Date of Patent: December 29, 1992
    Assignee: Burroughs Wellcome Co.
    Inventors: Joel Van Tuttle, Thomas A. Krenitsky
  • Antiviral compounds
    Patent number: 5070078
    Abstract: 2',3'-Dideoxy-3'-fluoro pyrimidine nucleosides particularly 2',3'-dideoxy-3'-fluorothymidine have been found to have particularly potent activity against adenovirus infections especially those caused by adenoviruses of serotype 8. Such compounds are preferably presented in pharmaceutical formulations adapted for ophthalmic administration.
    Type: Grant
    Filed: August 19, 1988
    Date of Patent: December 3, 1991
    Assignee: Burroughs Wellcome Co.
    Inventors: John W. T. Selway, Lowrie M. Beacham, III, Susan M. Daluge, Joel Van Tuttle, Thomas A. Krenitsky